Werkgroep Cardiologische centra Nederland English

CLEAR 1002-043 (Inclusie)

A randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant
Middel
bepedoic acid
Populatie
ASCVD
Fase
III
Jaar aanvang
2016

Studiedirecteur

dr. E. Ronner (Cardioloog)
Delft, Reinier de Graaf Gasthuis